Skip to content

Routine immunisation schedules for Wales

Click on the links in the table for more information about the disease each vaccine protects against.

The complete routine immunisation schedule for Wales from September 2026

Age due Diseases protected against Vaccine Name Usual site
8 weeks old Diphtheria, tetanus, pertussis (Whooping cough), polio, Hib and hepatitis B DTaP/IPV/Hib/ HepB (6-in-1) Infanrix hexa or Vaxelis Thigh
8 weeks old Meningococcal group B (MenB) MenB Bexsero Thigh
8 weeks old Rotavirus gastroenteritis Rotavirus Rotarix By mouth
12 weeks old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B DTaP/IPV/Hib/ HepB (6-in-1) Infanrix hexa or Vaxelis Thigh
12 weeks old MenB MenB Bexero Thigh
12 weeks old Rotavirus gastroenteritis Rotavirus Rotarix By mouth
16 weeks old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B DTaP/IPV/Hib/ HepB (6-in-1) Infanrix hexa or Vaxelis Thigh
16 weeks old Pneumococcal PCV13 Prevenar 131 Thigh
12 months old Pneumococcal PCV13 Prevenar 131 Upper arm/ thigh
12 months old MenB MenB Bexero Upper arm/ thigh
12 months old Measles, mumps, rubella and varicella (chickenpox)  MMRV ProQuad or Priorix-Tetra Upper arm/ thigh
18 months old Born before 1 July 2024:
No appointment

Born on or after 1 July 2024: Measles, mumps, rubella and varicella (chickenpox) 
MMRV ProQuad or Priorix-Tetra Upper arm/thigh
18 months old Born before 1 July 2024:
No appointment

Born on or after 1 July 2024:
Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B
DTaP/IPV/Hib/HepB (6-in-1) Infanrix hexa or Vaxelis Upper arm/thigh
22 and 3 years old and all school aged children Influenza (annually from September) Live attenuated influenza vaccine Fluenz3 Both nostrils
3 years 4 months old Diphtheria, tetanus, pertussis and polio dTaP/IPV (4-in-1) Repevax Upper arm
3 years 4 months old Born before 1 January 2025: Measles, mumps, rubella and varicella (chickenpox) 

Born on or after 1 January 2025: No MMRV vaccine
MMRV ProQuad or Priorix-Tetra Upper arm
School year 8 (12 to 13 year olds) Cancers and genital warts caused by specific human papillomavirus (HPV) types HPV4 (one dose) Gardasil 9 Upper arm
School year 9
(13 to 14 year olds)
Tetanus, diphtheria and polio Td/IPV (3-in-1) (check MMR status) Revaxis Upper arm
School year 9
(13 to 14 year olds)
Meningococcal groups A, C, W and Y MenACWY Nimenrix or MenQuadfi Upper arm
65 years of age and older Influenza (annually) Inactivated influenza vaccine Inactivated influenza vaccine  Upper arm
65 years of age and older Pneumococcal PCV205 Prevenar 20 Upper arm
65 years old and 70 to 79 years old   Shingles Shingles Shingrix Upper arm
75 years old and older 

(plus people who live in a care home for older adults) 
Respiratory Syncytial Virus (RSV)  RSV Abrysvo Upper arm

1  Refer to the Green Book Chapter: Pneumococcal – table 3 (external site) for babies with asplenia, splenic dysfunction, complement disorder or severely immunocompromised. 

2 Children must be 2 years old by 31 August to receive influenza vaccine in the routine programme in autumn/winter.

3 If Fluenz  is unsuitable, use an inactivated flu vaccine. 

4 Check the relevant chapter of the Green Book for individuals requiring a 3-dose schedule.

5 Remaining local stocks of PPV23 should be used first for the over 65s and for some clinical risk groups. Refer to the Green Book Chapter: Pneumococcal  (external site) for more information.

Selective immunisation programmes

Group Age and schedule Disease Vaccines
Babies born to hepatitis B infected mothers At birth and 4 weeks of age1 Hepatitis B Hepatitis B vaccines 
(Engerix B / HBvaxPRO) 
Infants in areas of the country with TB incidence at least 40 per 100,000  From birth Tuberculosis BCG 
Infants with a parent or grandparent born in a high incidence country2 From birth
Tuberculosis
BCG
People in a risk group for influenza3 From 6 months to 64 years Influenza Age-appropriate flu vaccine3
People in a risk group for RSV4  From 65 to 74 years  RSV  Abrysvo 
Pregnant women From 16 weeks of pregnancy Pertussis Tdap (ADACEL)  
If ADACEL is unavailable or contraindicated, administer dTaP/IPV (Repevax)
Pregnant women From 28 weeks of pregnancy  Respiratory syncytial virus (RSV) Abrysvo
Pregnant women At any stage in pregnancy during the flu season Influenza Inactivated flu vaccine3
Gay, bisexual and other men who have sex with men 45 years of age and under5
HPV5 Gardasil 9
People at increased risk of mpox6 Based on risk Mpox Imvanex
People at increased risk of gonorrhoea6
Based on risk Gonorrhoea Bexsero
People experiencing homelessness (from 1 October 2026)3,7  Any age  Influenza  
Pneumococcal
Inactivated flu vaccine3
PCV207 

1  In addition to the hexavalent vaccine (Infanrix hexa or Vaxelis) given at 8, 12, 16 weeks and, for children born on or after 1 July 2024, also at 18 months. Take a blood sample for HBsAg at 12 to 18 months to exclude infection. See the Selective neonatal Hepatitis B immunisation pathway | GOV.WALES (external site)

2  Where the annual incidence of TB is at least 40 per 100,000, see the WHO country profile.

3  Refer to the annual influenza (flu)  Welsh Health Circular (external site) for eligibility criteria and vaccine recommendations.

4 RSV vaccination is offered to people aged 65–74 with chronic respiratory disease or immunosuppression due to disease or treatment. For a list of eligible conditions, read: Update on RSV vaccination programme 2026 (WHC/2026/020) | GOV.WALES (external site).

5 Check the Green Book Chapter: HPV (external site) for individuals requiring a 1, 2 or 3 dose schedule. 

6 A sexual health clinician will assess individuals attending the sexual health clinic and advise vaccination if required.

7 Refer to the Pneumococcal Welsh Health Circular (WHC/2026/023) (external site) and Green Book: Pneumococcal (external site) for further details. 

Additional vaccines for individuals with underlying medical conditions1

Medical condition2 Diseases protected against Vaccines required2
Asplenia, splenic dysfunction (Including people with coeliac disease who have splenic dysfunction, and all haemoglobinopathies such as homozygous sickle cell disease)  

Complement disorder (including people receiving complement inhibitor therapy)
Meningococcal groups A, B, C, W and Y
Meningococcal B 
Pneumococcal
Influenza
MenACWY 
MenB 
PCV203
Annual flu vaccine4
Cochlear implants, cerebrospinal fluid leaks Pneumococcal PCV20 (from two years of age)3
Chronic respiratory and heart conditions
(such as moderate  to severe asthma, chronic pulmonary disease, and heart failure)
Pneumococcal
Influenza
PCV20 (from two years of age)3
Annual flu vaccine4
Chronic neurological conditions
(such as Parkinson’s or motor neurone disease, or learning disability)
Pneumococcal (only if the individual is also at increased risk of aspiration)
Influenza
PCV20 (from two years of age)3
Annual flu vaccine4
Diabetes Pneumococcal
Influenza
PCV20 (from two years of age)3
Annual flu vaccine4
Chronic kidney disease (CKD)
(including haemodialysis)
Pneumococcal (stage 4 and 5 CKD)
Influenza (stage 3, 4 and 5 CKD)
Hepatitis B (stage 4 and 5 CKD)
PCV20 (from two years of age)3
Annual flu vaccine4
Hepatitis B
Chronic liver conditions Pneumococcal
Influenza
Hepatitis A & B
PCV20 (from two years of age)3
Annual flu vaccine4
Hepatitis A
Hepatitis B
Haemophilia Hepatitis A & B Hepatitis A
Hepatitis B
Immunosuppression due to disease or treatment5 Pneumococcal
Influenza
PCV203
Annual flu vaccine4
Severe immunosuppression5 Pneumococcal
Influenza
Shingles
PCV203
Annual flu vaccine4
Shingrix (aged 18 years and over) 

1 The list is not exhaustive. Other vaccines may be recommended for certain individuals. 

2 Check relevant chapter of the Green Book for specific schedule and for further detail.

3 For detailed guidance and further information about pneumococcal vaccines for clinical risk groups, see Table 3 of the Green Book Chapter: Pneumococcal (external site).

4 From six months of age.

5 Consider annual influenza vaccination for household members and those who care for people with immunosuppression.